|
1
|
Klubo-Gwiezdzinska J, Yang L, Merkel R,
Patel D, Nilubol N, Merino MJ, Skarulis M, Sadowski SM and Kebebew
E: Results of screening in familial non-medullary thyroid cancer.
Thyroid. 27:1017–1024. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aschebrook-Kilfoy B, James B, Nagar S,
Kaplan S, Seng V, Ahsan H, Angelos P, Kaplan EL, Guerrero MA, Kuo
JH, et al: Risk factors for decreased quality of life in thyroid
cancer survivors: Initial findings from the North American thyroid
cancer survivorship study. Thyroid. 25:1313–1321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grogan RH, Kaplan SP, Cao H, Weiss RE,
Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL and Schechter
RB: A study of recurrence and death from papillary thyroid cancer
with 27 years of median follow-up. Surgery. 154:1436–1447. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gillanders SL and O'Neill JP: Prognostic
markers in well differentiated papillary and follicular thyroid
cancer (WDTC). Eur J Surg Oncol. 44:286–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeong S, Lee J, Kim D, Seol MY, Lee WK,
Jeong JJ, Nam KH, Jung SG, Shin DY, Lee EJ, et al: Relationship of
focally amplified long noncoding on chromosome 1 (FAL1) lncRNA with
E2F transcription factors in thyroid cancer. Medicine (Baltimore).
95:e25922016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hao S, Yao L, Huang J, He H, Yang F, Di Y,
Jin C and Fu D: Genome-wide analysis identified a number of
dysregulated long noncoding RNA (lncRNA) in human pancreatic ductal
adenocarcinoma. Technol Cancer Res Treat. 17:15330346177484292018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ponzio G, Rezzonico R, Bourget I, Allan R,
Nottet N, Popa A, Magnone V, Rios G, Mari B and Barbry P: A new
long noncoding RNA (lncRNA) is induced in cutaneous squamous cell
carcinoma and down-regulates several anticancer and cell
differentiation genes in mouse. J Biol Chem. 292:12483–12495. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao JH, Sun JX, Song YX, Chen XW, Yang
YC, Ma B, Wang J, Gao P and Wang ZN: A novel long noncoding
RNA-LOWEG is low expressed in gastric cancer and acts as a tumor
suppressor by inhibiting cell invasion. J Cancer Res Clin Oncol.
142:601–609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen C, Zhou L, Wang H, Chen J, Li W, Liu
W, Shen M, Liu H and Fu X: Long noncoding RNA CNALPTC1 promotes
cell proliferation and migration of papillary thyroid cancer via
sponging miR-30 family. Am J Cancer Res. 8:192–206. 2018.PubMed/NCBI
|
|
11
|
Li T, Yang XD, Ye CX, Shen ZL, Yang Y,
Wang B, Guo P, Gao ZD, Ye YJ, Jiang KW and Wang S: Long noncoding
RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and
tumor progression by upregulating the expression of high mobility
group AT-hook 2 (HMGA2) gene. Cell Cycle. 16:224–231. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jendrzejewski J, He H, Radomska HS, Li W,
Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R and de la Chapelle
A: The polymorphism rs944289 predisposes to papillary thyroid
carcinoma through a large intergenic noncoding RNA gene of tumor
suppressor type. Proc Natl Acad Sci USA. 109:8646–8651. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jendrzejewski J, Thomas A, Liyanarachchi
S, Eiterman A, Tomsic J, He H, Radomska HS, Li W, Nagy R, Sworczak
K and de la Chapelle A: PTCSC3 is involved in papillary thyroid
carcinoma development by modulating S100A4 gene expression. J Clin
Endocrinol Metab. 100:E1370–E1377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng H, Wang M, Jiang L, Chu H, Hu J,
Ning J, Li B, Wang D and Xu J: BRAF-activated long noncoding RNA
modulates papillary thyroid carcinoma cell proliferation through
regulating thyroid stimulating hormone receptor. Cancer Res Treat.
48:698–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Hu
J and Sun Y: BRAF-activated long non-coding RNA contributes to cell
proliferation and activates autophagy in papillary thyroid
carcinoma. Oncol Lett. 8:1947–1952. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mei JM and Niu CS: Effects of CDNF on
6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax
and caspase-3 activation. Neurol Sci. 35:1275–1280. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pal MK, Jaiswar SP, Srivastav AK, Goyal S,
Dwivedi A, Verma A, Singh J, Pathak AK, Sankhwar PL and Ray RS:
Synergistic effect of piperine and paclitaxel on cell fate via
cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas
SKOV-3 cells. Eur J Pharmacol. 791:751–762. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao YX, Zhang ZP, Zhao J and Liu JP:
Effects of fibronectin 1 on cell proliferation, senescence and
apoptosis of human glioma cells through the PI3K/AKT signaling
pathway. Cell Physiol Biochem. 48:1382–1396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou Y, Li S, Li J, Wang D and Li Q:
Effect of microRNA-135a on cell proliferation, migration, invasion,
apoptosis and tumor angiogenesis through the IGF-1/PI3K/Akt
signaling pathway in non-small cell lung cancer. Cell Physiol
Biochem. 42:1431–1446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Oliveira JC, Oliveira LC, Mathias C,
Pedroso GA, Lemos DS, Salviano-Silva A, Jucoski TS, Lobo-Alves SC,
Zambalde EP, Cipolla GA and Gradia DF: Long non-coding RNAs in
cancer: Another layer of complexity. J Gene Med.
21:e30652019.PubMed/NCBI
|
|
23
|
Tang Y, Soroush F, Tong Z, Kiani MF and
Wang B: Targeted multidrug delivery system to overcome
chemoresistance in breast cancer. Int J Nanomedicine. 12:671–681.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan J, Zhang Y, She Q, Li X, Peng L, Wang
X, Liu S, Shen X, Zhang W, Dong Y, et al: Long noncoding RNA
H19/miR-675 axis promotes gastric cancer via FADD/Caspase 8/Caspase
3 signaling pathway. Cell Physiol Biochem. 42:2364–2376. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu Y, Wang Z, Jiang X and Cui Y:
Overexpression of long noncoding RNA H19 indicates a poor prognosis
for cholangiocarcinoma and promotes cell migration and invasion by
affecting epithelial-mesenchymal transition. Biomed Pharmacother.
92:17–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rothhut B, Ghoneim C, Antonicelli F and
Soula-Rothhut M: Epidermal growth factor stimulates matrix
metalloproteinase-9 expression and invasion in human follicular
thyroid carcinoma cells through focal adhesion kinase. Biochimie.
89:613–624. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dettmer M, Perren A, Moch H, Komminoth P,
Nikiforov YE and Nikiforova MN: Comprehensive MicroRNA expression
profiling identifies novel markers in follicular variant of
papillary thyroid carcinoma. Thyroidology. 23:1383–1389. 2013.
View Article : Google Scholar
|
|
28
|
Murugan AK, Munirajan AK and Alzahrani AS:
Long noncoding RNAs: Emerging players in thyroid cancer
pathogenesis. Endocr Relat Cancer. 25:R59–R82. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang P, Liu G, Xu W, Liu H, Bu Q and Sun
D: Long noncoding RNA H19 inhibits cell viability, migration, and
invasion via downregulation of IRS-1 in thyroid cancer cells.
Technol Cancer Res Treat. 16:1102–1112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mahmoudian-Sani MR, Jalali A, Jamshidi M,
Moridi H, Alghasi A, Shojaeian A and Mobini GR: Long non-coding
RNAs in thyroid cancer: Implications for pathogenesis, diagnosis,
and therapy. Oncol Res Treat. 42:136–142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu N, Zhou Q, Qi YH, Wang H, Yang L and
Fan QY: Effects of long non-coding RNA H19 and microRNA let7a
expression on thyroid cancer prognosis. Exp Mol Pathol. 103:71–77.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee KT, Gopalan V and Lam AK: Roles of
long-non-coding RNAs in cancer therapy through the PI3K/Akt
signalling pathway. Histol Histopathol. 34:593–609. 2019.PubMed/NCBI
|
|
33
|
Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D
and Quan ZW: Long noncoding RNA H19 contributes to gallbladder
cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Tumour Biol. 37:9721–9730. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liao Z, Zhao J and Yang Y: Downregulation
of lncRNA H19 inhibits the migration and invasion of melanoma cells
by inactivating the NF-κB and PI3K/Akt signaling pathways. Mol Med
Rep. 17:7313–7318. 2018.PubMed/NCBI
|
|
35
|
Renault TT, Dejean LM and Manon S: A
brewing understanding of the regulation of Bax function by Bcl-xL
and Bcl-2. Mech Ageing Dev. 161:201–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feng K, Liu Y, Xu LJ, Zhao LF, Jia CW and
Xu MY: Long noncoding RNA PVT1 enhances the viability and invasion
of papillary thyroid carcinoma cells by functioning as ceRNA of
microRNA-30a through mediating expression of insulin like growth
factor 1 receptor. Biomed Pharmacother. 104:686–698. 2018.
View Article : Google Scholar : PubMed/NCBI
|
